Cell‐free DNA 5‐hydroxymethylcytosine as a marker for common cancer detection-Reference-Cited by-同舟云学术

Cell‐free DNA 5‐hydroxymethylcytosine as a marker for common cancer detection

Published:2022-10-10 Issue:4 Volume:2 Page:
ISSN:2768-0622
Container-title:Clinical and Translational Discovery
language:en
Short-container-title:Clinical and Translational Dis

Author:

Shao Jianming¹,Bernicker Eric H.²,He Chuan³⁴,Li Zejuan¹⁵^ORCID

Affiliation:

1. Department of Pathology and Genomic Medicine Houston Methodist Hospital Houston Methodist Research Institute Houston Texas USA

2. Cancer Center Houston Methodist Hospital Houston Texas USA

3. Department of Chemistry Department of Biochemistry and Molecular Biology Institute for Biophysical Dynamics The University of Chicago Chicago Illinois USA

4. Howard Hughes Medical Institute The University of Chicago Chicago Illinois USA

5. Department of Pathology and Laboratory Medicine Weill Cornell Medical College New York New York USA

Funder

National Human Genome Research Institute

American Cancer Society

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctd2.136

Reference65 articles.

1. Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications;Genes;2024-09-03

2. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer;Cells;2024-04-19

3. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis;Cells;2024-02-06

4. Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia;Clinical Epigenetics;2023-08-24

5. Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine;Genes;2023-05-28